866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Retinal Drugs and Biologics Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 118 Pages

In this report, the EMEA Retinal Drugs and Biologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Retinal Drugs and Biologics for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Retinal Drugs and Biologics market competition by top manufacturers/players, with Retinal Drugs and Biologics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Alimera Sciences
Janssen Biotech
F. Hoffmann-La Roche Ltd
Genzyme Corporation
Ocular Therapeutix
UCBCares
Allergan
AbbVie Inc
Swedish Orphan Biovitrum
Bristol-Myers Squibb Company
Genentech USA
Bausch & Lomb Incorporated

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Surgery
Medicines
Retinal Laser
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Retinal Drugs and Biologics for each application, including
Hospital Pharmacies
Retail Pharmacies
Specialty Ophthalmology Clinics
Others
Table of Contents

EMEA (Europe, Middle East and Africa) Retinal Drugs and Biologics Market Report 2017
1 Retinal Drugs and Biologics Overview
1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Classification of Retinal Drugs and Biologics
1.2.1 EMEA Retinal Drugs and Biologics Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Retinal Drugs and Biologics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Surgery
1.2.4 Medicines
1.2.5 Retinal Laser
1.2.6 Others
1.3 EMEA Retinal Drugs and Biologics Market by Application/End Users
1.3.1 EMEA Retinal Drugs and Biologics Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Specialty Ophthalmology Clinics
1.3.5 Others
1.4 EMEA Retinal Drugs and Biologics Market by Region
1.4.1 EMEA Retinal Drugs and Biologics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Retinal Drugs and Biologics (2012-2022)
1.5.1 EMEA Retinal Drugs and Biologics Sales and Growth Rate (2012-2022)
1.5.2 EMEA Retinal Drugs and Biologics Revenue and Growth Rate (2012-2022)

2 EMEA Retinal Drugs and Biologics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Retinal Drugs and Biologics Market Competition by Players/Manufacturers
2.1.1 EMEA Retinal Drugs and Biologics Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Retinal Drugs and Biologics Revenue and Share by Players (2012-2017)
2.1.3 EMEA Retinal Drugs and Biologics Sale Price by Players (2012-2017)
2.2 EMEA Retinal Drugs and Biologics (Volume and Value) by Type/Product Category
2.2.1 EMEA Retinal Drugs and Biologics Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Retinal Drugs and Biologics Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Retinal Drugs and Biologics Sale Price by Type (2012-2017)
2.3 EMEA Retinal Drugs and Biologics (Volume) by Application
2.4 EMEA Retinal Drugs and Biologics (Volume and Value) by Region
2.4.1 EMEA Retinal Drugs and Biologics Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Retinal Drugs and Biologics Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Retinal Drugs and Biologics Sales Price by Region (2012-2017)

3 Europe Retinal Drugs and Biologics (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Retinal Drugs and Biologics Sales and Value (2012-2017)
3.1.1 Europe Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
3.2 Europe Retinal Drugs and Biologics Sales and Market Share by Type
3.3 Europe Retinal Drugs and Biologics Sales and Market Share by Application
3.4 Europe Retinal Drugs and Biologics Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Retinal Drugs and Biologics Sales Volume by Countries (2012-2017)
3.4.2 Europe Retinal Drugs and Biologics Revenue by Countries (2012-2017)
3.4.3 Germany Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
3.4.4 France Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
3.4.5 UK Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
3.4.6 Russia Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
3.4.7 Italy Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
3.4.8 Benelux Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)

4 Middle East Retinal Drugs and Biologics (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Retinal Drugs and Biologics Sales and Value (2012-2017)
4.1.1 Middle East Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
4.2 Middle East Retinal Drugs and Biologics Sales and Market Share by Type
4.3 Middle East Retinal Drugs and Biologics Sales and Market Share by Application
4.4 Middle East Retinal Drugs and Biologics Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Retinal Drugs and Biologics Sales Volume by Countries (2012-2017)
4.4.2 Middle East Retinal Drugs and Biologics Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
4.4.4 Israel Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
4.4.5 UAE Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
4.4.6 Iran Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)

5 Africa Retinal Drugs and Biologics (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Retinal Drugs and Biologics Sales and Value (2012-2017)
5.1.1 Africa Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
5.2 Africa Retinal Drugs and Biologics Sales and Market Share by Type
5.3 Africa Retinal Drugs and Biologics Sales and Market Share by Application
5.4 Africa Retinal Drugs and Biologics Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Retinal Drugs and Biologics Sales Volume by Countries (2012-2017)
5.4.2 Africa Retinal Drugs and Biologics Revenue by Countries (2012-2017)
5.4.3 South Africa Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
5.4.5 Egypt Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
5.4.6 Algeria Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)

6 EMEA Retinal Drugs and Biologics Manufacturers/Players Profiles and Sales Data
6.1 Alimera Sciences
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Janssen Biotech
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 F. Hoffmann-La Roche Ltd
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Genzyme Corporation
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Genzyme Corporation Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Ocular Therapeutix
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Ocular Therapeutix Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 UCBCares
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 UCBCares Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Allergan
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Allergan Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 AbbVie Inc
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 AbbVie Inc Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Swedish Orphan Biovitrum
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Bristol-Myers Squibb Company
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Retinal Drugs and Biologics Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Genentech USA
6.12 Bausch & Lomb Incorporated

7 Retinal Drugs and Biologics Manufacturing Cost Analysis
7.1 Retinal Drugs and Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Retinal Drugs and Biologics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Retinal Drugs and Biologics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Retinal Drugs and Biologics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Retinal Drugs and Biologics Market Forecast (2017-2022)
11.1 EMEA Retinal Drugs and Biologics Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Retinal Drugs and Biologics Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Retinal Drugs and Biologics Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Retinal Drugs and Biologics Price and Trend Forecast (2017-2022)
11.2 EMEA Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Retinal Drugs and Biologics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Retinal Drugs and Biologics Sales Forecast by Type (2017-2022)
11.7 EMEA Retinal Drugs and Biologics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Retinal Drugs and Biologics
Figure EMEA Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Retinal Drugs and Biologics Sales Volume Market Share by Type (Product Category) in 2016
Figure Surgery Product Picture
Figure Medicines Product Picture
Figure Retinal Laser Product Picture
Figure Others Product Picture
Figure EMEA Retinal Drugs and Biologics Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Retinal Drugs and Biologics by Application in 2016
Figure Hospital Pharmacies Examples
Figure Retail Pharmacies Examples
Figure Specialty Ophthalmology Clinics Examples
Figure Others Examples
Figure EMEA Retinal Drugs and Biologics Market Size (Million USD) by Region (2012-2022)
Figure Europe Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Retinal Drugs and Biologics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Retinal Drugs and Biologics Revenue (Million USD) Status and Forecast by Countries
Figure Africa Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Retinal Drugs and Biologics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Retinal Drugs and Biologics Sales Volume and Growth Rate (2012-2022)
Figure EMEA Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Retinal Drugs and Biologics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Retinal Drugs and Biologics Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Retinal Drugs and Biologics Sales Share by Players (2012-2017)
Figure 2016 Retinal Drugs and Biologics Sales Share by Players
Figure 2017 Retinal Drugs and Biologics Sales Share by Players
Figure EMEA Retinal Drugs and Biologics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Retinal Drugs and Biologics Revenue (Million USD) by Players (2012-2017)
Table EMEA Retinal Drugs and Biologics Revenue Share by Players (2012-2017)
Table 2016 EMEA Retinal Drugs and Biologics Revenue Share by Players
Table 2017 EMEA Retinal Drugs and Biologics Revenue Share by Players
Table EMEA Retinal Drugs and Biologics Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Retinal Drugs and Biologics Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Retinal Drugs and Biologics Sales Share by Type (2012-2017)
Figure Sales Market Share of Retinal Drugs and Biologics by Type (2012-2017)
Figure EMEA Retinal Drugs and Biologics Sales Market Share by Type (2012-2017)
Table EMEA Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Retinal Drugs and Biologics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Retinal Drugs and Biologics by Type in 2016
Table EMEA Retinal Drugs and Biologics Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Retinal Drugs and Biologics Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Retinal Drugs and Biologics Sales Share by Application (2012-2017)
Figure Sales Market Share of Retinal Drugs and Biologics by Application (2012-2017)
Figure EMEA Retinal Drugs and Biologics Sales Market Share by Application in 2016
Table EMEA Retinal Drugs and Biologics Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Retinal Drugs and Biologics Sales Share by Region (2012-2017)
Figure Sales Market Share of Retinal Drugs and Biologics by Region (2012-2017)
Figure EMEA Retinal Drugs and Biologics Sales Market Share in 2016
Table EMEA Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Retinal Drugs and Biologics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Retinal Drugs and Biologics by Region (2012-2017)
Figure EMEA Retinal Drugs and Biologics Revenue Market Share Regions in 2016
Table EMEA Retinal Drugs and Biologics Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
Table Europe Retinal Drugs and Biologics Sales (K Units) by Type (2012-2017)
Table Europe Retinal Drugs and Biologics Market Share by Type (2012-2017)
Figure Europe Retinal Drugs and Biologics Market Share by Type in 2016
Table Europe Retinal Drugs and Biologics Sales (K Units) by Application (2012-2017)
Table Europe Retinal Drugs and Biologics Market Share by Application (2012-2017)
Figure Europe Retinal Drugs and Biologics Market Share by Application in 2016
Table Europe Retinal Drugs and Biologics Sales (K Units) by Countries (2012-2017)
Table Europe Retinal Drugs and Biologics Sales Market Share by Countries (2012-2017)
Figure Europe Retinal Drugs and Biologics Sales Market Share by Countries (2012-2017)
Figure Europe Retinal Drugs and Biologics Sales Market Share by Countries in 2016
Table Europe Retinal Drugs and Biologics Revenue (Million USD) by Countries (2012-2017)
Table Europe Retinal Drugs and Biologics Revenue Market Share by Countries (2012-2017)
Figure Europe Retinal Drugs and Biologics Revenue Market Share by Countries (2012-2017)
Figure Europe Retinal Drugs and Biologics Revenue Market Share by Countries in 2016
Figure Germany Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure France Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure UK Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Retinal Drugs and Biologics Sales (K Units) by Type (2012-2017)
Table Middle East Retinal Drugs and Biologics Market Share by Type (2012-2017)
Figure Middle East Retinal Drugs and Biologics Market Share by Type (2012-2017)
Table Middle East Retinal Drugs and Biologics Sales (K Units) by Applications (2012-2017)
Table Middle East Retinal Drugs and Biologics Market Share by Applications (2012-2017)
Figure Middle East Retinal Drugs and Biologics Sales Market Share by Application in 2016
Table Middle East Retinal Drugs and Biologics Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Retinal Drugs and Biologics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Retinal Drugs and Biologics Sales Volume Market Share by Countries in 2016
Table Middle East Retinal Drugs and Biologics Revenue (Million USD) by Countries (2012-2017)
Table Middle East Retinal Drugs and Biologics Revenue Market Share by Countries (2012-2017)
Figure Middle East Retinal Drugs and Biologics Revenue Market Share by Countries (2012-2017)
Figure Middle East Retinal Drugs and Biologics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Retinal Drugs and Biologics Sales (K Units) by Type (2012-2017)
Table Africa Retinal Drugs and Biologics Sales Market Share by Type (2012-2017)
Figure Africa Retinal Drugs and Biologics Sales Market Share by Type (2012-2017)
Figure Africa Retinal Drugs and Biologics Sales Market Share by Type in 2016
Table Africa Retinal Drugs and Biologics Sales (K Units) by Application (2012-2017)
Table Africa Retinal Drugs and Biologics Sales Market Share by Application (2012-2017)
Figure Africa Retinal Drugs and Biologics Sales Market Share by Application (2012-2017)
Table Africa Retinal Drugs and Biologics Sales Volume (K Units) by Countries (2012-2017)
Table Africa Retinal Drugs and Biologics Sales Market Share by Countries (2012-2017)
Figure Africa Retinal Drugs and Biologics Sales Market Share by Countries (2012-2017)
Figure Africa Retinal Drugs and Biologics Sales Market Share by Countries in 2016
Table Africa Retinal Drugs and Biologics Revenue (Million USD) by Countries (2012-2017)
Table Africa Retinal Drugs and Biologics Revenue Market Share by Countries (2012-2017)
Figure Africa Retinal Drugs and Biologics Revenue Market Share by Countries (2012-2017)
Figure Africa Retinal Drugs and Biologics Revenue Market Share by Countries in 2016
Figure South Africa Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Table Alimera Sciences Retinal Drugs and Biologics Basic Information List
Table Alimera Sciences Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alimera Sciences Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Alimera Sciences Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure Alimera Sciences Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table Janssen Biotech Retinal Drugs and Biologics Basic Information List
Table Janssen Biotech Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Biotech Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Janssen Biotech Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure Janssen Biotech Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Basic Information List
Table F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table Genzyme Corporation Retinal Drugs and Biologics Basic Information List
Table Genzyme Corporation Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure Genzyme Corporation Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table Ocular Therapeutix Retinal Drugs and Biologics Basic Information List
Table Ocular Therapeutix Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure Ocular Therapeutix Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table UCBCares Retinal Drugs and Biologics Basic Information List
Table UCBCares Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure UCBCares Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure UCBCares Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure UCBCares Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table Allergan Retinal Drugs and Biologics Basic Information List
Table Allergan Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Allergan Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure Allergan Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table AbbVie Inc Retinal Drugs and Biologics Basic Information List
Table AbbVie Inc Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Inc Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure AbbVie Inc Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure AbbVie Inc Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Basic Information List
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Company Retinal Drugs and Biologics Basic Information List
Table Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Revenue Market Share in EMEA (2012-2017)
Table Genentech USA Retinal Drugs and Biologics Basic Information List
Table Bausch & Lomb Incorporated Retinal Drugs and Biologics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Retinal Drugs and Biologics
Figure Manufacturing Process Analysis of Retinal Drugs and Biologics
Figure Retinal Drugs and Biologics Industrial Chain Analysis
Table Raw Materials Sources of Retinal Drugs and Biologics Major Manufacturers in 2016
Table Major Buyers of Retinal Drugs and Biologics
Table Distributors/Traders List
Figure EMEA Retinal Drugs and Biologics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Retinal Drugs and Biologics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Retinal Drugs and Biologics Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Retinal Drugs and Biologics Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Retinal Drugs and Biologics Sales Market Share Forecast by Region (2017-2022)
Table EMEA Retinal Drugs and Biologics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Retinal Drugs and Biologics Revenue Market Share Forecast by Region (2017-2022)
Table Europe Retinal Drugs and Biologics Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Retinal Drugs and Biologics Sales Market Share Forecast by Countries (2017-2022)
Table Europe Retinal Drugs and Biologics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Retinal Drugs and Biologics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Retinal Drugs and Biologics Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Retinal Drugs and Biologics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Retinal Drugs and Biologics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Retinal Drugs and Biologics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Retinal Drugs and Biologics Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Retinal Drugs and Biologics Sales Market Share Forecast by Countries (2017-2022)
Table Africa Retinal Drugs and Biologics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Retinal Drugs and Biologics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Retinal Drugs and Biologics Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Retinal Drugs and Biologics Sales Market Share Forecast by Type (2017-2022)
Table EMEA Retinal Drugs and Biologics Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Retinal Drugs and Biologics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *